Cart
sales@molnova.com
5-(2-Furyl)-2-hydroxybenzoic acid
CAS No. 893739-96-3
5-(2-Furyl)-2-hydroxybenzoic acid( —— )
Catalog No. M35971 CAS No. 893739-96-3
5-(2-Furyl)-2-hydroxybenzoic acid is an inhibitor of glycolate oxidase (GO) and can be used to study metabolism-related disorders such as primary hyperoxaluria type 1 (PH1).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 160 | Get Quote |
|
| 5MG | 242 | Get Quote |
|
| 10MG | 357 | Get Quote |
|
| 25MG | 576 | Get Quote |
|
| 50MG | 818 | Get Quote |
|
| 100MG | 1062 | Get Quote |
|
| 500MG | 2403 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name5-(2-Furyl)-2-hydroxybenzoic acid
-
NoteResearch use only, not for human use.
-
Brief Description5-(2-Furyl)-2-hydroxybenzoic acid is an inhibitor of glycolate oxidase (GO) and can be used to study metabolism-related disorders such as primary hyperoxaluria type 1 (PH1).
-
DescriptionLDH-IN-2, a salicylic acid derivative, is an inhibitor of glycolate oxidase (GO). LDH-IN-2 decreases oxalate output in hyperoxaluric hepatocytes. LDH-IN-2 can be used for research of primary hyperoxaluria type 1 (PH1).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number893739-96-3
-
Formula Weight204.18
-
Molecular FormulaC11H8O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(O)C=1C=C(C=CC1O)C=2OC=CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Moya-Garzón MD, et al. Salicylic Acid Derivatives Inhibit Oxalate Production in Mouse Hepatocytes with Primary Hyperoxaluria Type 1. J Med Chem. 2018 Aug 23;61(16):7144-7167. ?
molnova catalog
related products
-
PIN1 inhibitor API-1
PIN1 inhibitor API-1 is a specific Pin1 inhibitor (IC50: 72.3 nM). PIN1 inhibitor API-1 retains the active conformation of pXPO5 and restores the ability of pXPO5 to transport pre-miRNAs from the nucleus to cytoplasm, thus up-regulating the anticancer miRNA biogenesis to suppress both in vitro and in vivo hepatocellular carcinoma development.
-
LSKL Inhibitor of Th...
LSKL Inhibitor of Thrombospondin TSP-1(TSP-1) is activation of TGF-β .
-
D-Galactose
A kind of galactose.
